HEOR & RWE

Health economics and outcome research (HEOR) and real-world evidence (RWE) are key domains in the healthcare sector to inform decision and policy makers for a better understanding of potential healthcare resource use. HEOR assists decision-makers and policymakers in addressing health-related issues and making healthcare more equitable, accessible, and affordable to all patients, and RWE is viewed as a key driver of HEOR, aiming to increase the use of high-quality clinical research in clinical decision making and improve market access landscape reimbursement pathway.

Evidence Generation

Our experts support clients on both qualitative and quantitative evidence analysis using robust methodology.

• Systematic Literature Reviews (SLR) of clinical, economic, epidemiological studies, etc.
• Targeted Literature Review (TLR)
• Scoping and Rapid Review
• Meta-analysis
• Network meta-analysis (NMA) or mixed treatment comparison (MTC) using Frequentist and Bayesian approach
• Meta-regression and Sensitivity analysis

Our experts provide data-driven insights using RWD to support clients in gaining a more comprehensive understanding of a successful product development strategy.

• Observational data/database analysis
• Selection of relevant endpoints from the RWE studies to improve clinical trial design
• Identification of target population for the specific interventions
• Patient reported outcomes (PROs)/quality of life (QoL) data understanding to clarify unmet needs
• Epidemiological data for specific indication for the potential market landscape